β-glucocerebrosidase gene locus as a link for Gaucher's disease and familial hypo-α-lipoproteinaemia

Lancet

Volumn 351, Issue 9120, 1998, Pages 1919-1923

  Pocovi, Miguel ^e   Cenarro, Ana ^e   Civeira, Fernando ^b   Torralba, Miguel A ^a   Perez Calvo, Juan I ^a   Mozas, Pilar ^e   Giraldo, Pilar ^b   Giralt, Manuel ^b   Myers, Richard H ^c   Cupples, L Adrienne ^c   Ordovas, Jose M ^d  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TUFTS UNIVERSITY   (United States)

^e JM USDA Hum Nutr Res Ctr at T ^*

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; GLUCOSYLCERAMIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; DISEASE CARRIER; ENZYME ACTIVITY; ENZYME DEFICIENCY; EXON; FEMALE; GAUCHER DISEASE; GENE DELETION; GENE LOCUS; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPOLIPOPROTEINEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LYSOSOME STORAGE DISEASE; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; PRIORITY JOURNAL;

EID: 0032572381     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)09490-7     Document Type: Article

References (27)

1. 1 Beutler E, Grabowski GA. Gaucher disease. In: Scriver CR, Beudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease, 7th edn. New York: McGraw-Hill, 1995: 2641-70.
2. 2 Cormand B, Monfort M, Chabas A, Vilageliu L, Ginberg D. Genetic fine localization of the beta-glucocerebrosidase (GBA) and prosaposin (PSAP) genes: implications for Gaucher disease. Hum Genet 1997; 100: 75-77.
3. 3 Beutler E, Demina A, Gelbert T. Glucocerebrosidase mutations in Gaucher disease. Mol Med 1994; 1: 82-92.
4. 4 Mistry PK. Genotype/phenotype correlations in Gaucher's disease. Lancet 1995; 346: 982-83.
5. 5 Beutler E, Nguyen NJ, Henneberger MW, et al. Gaucher disease: gene frequencies in the Ashkenazi Jewish population. Am J Hum Genet 1993; 52: 85-88.
6. 6 DeMarchi JM, Caskey CT, Richards CS. Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews. Hum Mut 1996; 8: 116-25.
7. 7 Lacerda L, Amaral O, Pinto R, Oliveira P, Aerts J, Sa Miranda MC. Gaucher disease: N370S glucocerebrosidase gene frequency in the Portuguese population. Clin Genet 1994; 45: 298-300.
8. 8 Gaucher Disease: current issues in diagnosis and treatment. NIH Technol Assess Statement Online. 1995, Feb 27-March 1.
9. 9 Ginsberg H, Grabowski GA, Gibson JC, et al. Reduced plasma concentrations of total, low density lipoprotein and high density lipoprotein cholesterol in patients with Gaucher type I disease. Clin Genet 1984; 26: 109-16.
10. 10 Le NA, Gibson JC, Rubinstein A, Grabowski GA, Ginsberg HN. Abnormalities in lipoprotein metabolism in Gaucher type I disease. Metabolism 1988; 37: 240-45.
11. 11 Gordon DJ, Rifkind BM. High-density lipoprotein: the clinical implications of recent studies. N Engl J Med 1989; 321: 1311-16.
12. 12 Beutler E. Gaucher's disease. N Engl J Med 1991; 325: 1354-60.
13. 13 Raghavan SS, Topol J, Kolodny EH. Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease. Am J Hum Genet 1980; 32: 158-73.
14. 14 Miller S, Dykes D, Polensky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
15. 15 Beutler E, Gelbart T, West C. The facile detection of the nt 1226 mutation of glucocerebrosidase by mismatched PCR. Clin Chim Acta 1990; 194: 161-66.
16. 16 Laubscher KH, Glew RH, Lee RE, Okinaka RT. Use of denaturing gradient gel electrophoresis to identify mutant sequences in the beta-glucocerebrosidase gene. Hum Mutat 1994; 3: 411-15.
17. 17 Uchiyama A, Tomasu S, Kondo N, et al. New Gaucher disease mutations in exon 10: a novel L444R mutation produces a new NciI site the same as L444P. Hum Mol Genet 1994; 3: 1183-84.
18. 18 Beutler E, Gelbart T. Erroneous assignment of Gaucher disease genotype as consequence of a gene deletion. Hum Mutat 1994; 4: 212-26.
19. 19 Boerwinkle E, Sing CF. The use of genotype information in the analysis of quantitative phenotypes in man. III. Simultaneous estimation of the frequencies and effects of the apolipoprotein E polymorphism and residual polygenetic effects on cholesterol, betalipoprotein and triglyceride levels. Ann Hum Genet 1987; 51: 211-26.
20. 20 Zimran A, Sorge J, Gross E, Kubitz M, West C, Beutler E. Prediction of severity of Gaucher's disease by identification of mutations at DNA level. Lancet 1989; ii: 349-52.
21. 21 Grabowski GA. Gaucher disease: enzymology, genetics, and treatment. In: Harris H, Hirschhorn K, eds. Advances in human genetics. New York: Plenum Press, 1993: 377-441.
22. 22 Mazzone T, Gump H, Diller P, Getz GS. Macrophage free cholesterol content regulates apolipoprotein E synthesis. J Biol Chem 1987; 262: 11657-62.
23. 23 Zimran A, Gelbart T, Westwood B, Grabowski GA, Beutler E. High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews. Am J Hum Genet 1991; 49: 855-59.
24. 24 Amaral O, Lacerda L, Santos R, Pinto R, Aerts J, Sa Miranda MC. Type I Gaucher disease: molecular, biochemical and clinical characterization of patients from Northern Portugal. Biochem Med Metab Biol 1993; 49: 97-107.
25. 25 Middleton-Price HR, van den Berghe JA, Scott J, Knott TJ, Malcolm S. Regional chromosomal localisation of APOA2 to 1q21-1q23. Hum Genet 1988; 79: 283-85.
26. 26 Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271: 518-20.
27. 27 Franceschini G, Sirtori CR, Capurso A, Weisgraber KH, Mahley RW. A-I Milano apoprotein: decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest 1980; 66: 892-900.